Breanna Lee Zerfas, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteasome Endopeptidase Complex | 4 | 2020 | 1338 | 1.800 |
Why?
|
| Peptoids | 2 | 2019 | 7 | 1.420 |
Why?
|
| Peptides | 5 | 2023 | 4409 | 1.210 |
Why?
|
| Molecular Probes | 2 | 2023 | 316 | 0.790 |
Why?
|
| Fluoresceins | 1 | 2020 | 235 | 0.730 |
Why?
|
| Gramicidin | 1 | 2016 | 12 | 0.560 |
Why?
|
| Gram-Positive Bacteria | 1 | 2016 | 184 | 0.510 |
Why?
|
| Peptidomimetics | 1 | 2015 | 34 | 0.510 |
Why?
|
| Gram-Negative Bacteria | 1 | 2016 | 270 | 0.480 |
Why?
|
| Amino Acids | 1 | 2020 | 1736 | 0.480 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 1861 | 0.440 |
Why?
|
| Fluorescent Dyes | 1 | 2020 | 1917 | 0.430 |
Why?
|
| Lysine | 1 | 2016 | 1007 | 0.390 |
Why?
|
| Drug Design | 1 | 2015 | 1076 | 0.340 |
Why?
|
| Nervous System Diseases | 1 | 2019 | 1622 | 0.340 |
Why?
|
| Drug Delivery Systems | 1 | 2019 | 2219 | 0.320 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 2133 | 0.300 |
Why?
|
| Host-Pathogen Interactions | 1 | 2015 | 1477 | 0.270 |
Why?
|
| Immunologic Factors | 1 | 2015 | 1580 | 0.260 |
Why?
|
| Chromatography, Affinity | 1 | 2023 | 549 | 0.210 |
Why?
|
| Immunoproteins | 1 | 2019 | 3 | 0.180 |
Why?
|
| Ribulose-Bisphosphate Carboxylase | 1 | 2018 | 20 | 0.170 |
Why?
|
| Receptors, Opioid, delta | 1 | 2018 | 47 | 0.170 |
Why?
|
| Enzyme Assays | 1 | 2019 | 111 | 0.170 |
Why?
|
| Ubiquitination | 1 | 2022 | 1012 | 0.150 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 7181 | 0.150 |
Why?
|
| Oligopeptides | 2 | 2019 | 1189 | 0.150 |
Why?
|
| Protein Structure, Secondary | 1 | 2019 | 1246 | 0.140 |
Why?
|
| Substrate Specificity | 1 | 2020 | 1801 | 0.140 |
Why?
|
| Ligands | 1 | 2022 | 3282 | 0.130 |
Why?
|
| Molecular Structure | 1 | 2019 | 1899 | 0.120 |
Why?
|
| Cell Membrane Permeability | 1 | 2016 | 590 | 0.120 |
Why?
|
| Hemolysis | 1 | 2016 | 420 | 0.120 |
Why?
|
| Microscopy, Confocal | 1 | 2019 | 1970 | 0.120 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2015 | 362 | 0.110 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4204 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 6314 | 0.100 |
Why?
|
| Neoplasms | 1 | 2019 | 21683 | 0.090 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 3129 | 0.090 |
Why?
|
| Anti-Infective Agents | 1 | 2015 | 972 | 0.070 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 16689 | 0.060 |
Why?
|
| Endoribonucleases | 1 | 2023 | 229 | 0.050 |
Why?
|
| Enkephalin, Leucine | 1 | 2018 | 16 | 0.040 |
Why?
|
| Radioligand Assay | 1 | 2018 | 374 | 0.040 |
Why?
|
| Humans | 5 | 2020 | 744343 | 0.040 |
Why?
|
| Cricetulus | 1 | 2018 | 816 | 0.040 |
Why?
|
| CHO Cells | 1 | 2018 | 1406 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2018 | 1472 | 0.030 |
Why?
|
| Transfection | 1 | 2018 | 5892 | 0.020 |
Why?
|
| Animals | 2 | 2019 | 168757 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2018 | 5456 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2023 | 5853 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 10943 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2023 | 12208 | 0.010 |
Why?
|